Ulrich T. Hopt
University of Freiburg(DE)University Medical Center Freiburg(DE)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Pancreatitis Pathology and Treatment, Organ Transplantation Techniques and Outcomes, Neuroendocrine Tumor Research Advances, Gastric Cancer Management and Outcomes
Most-Cited Works
- → The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs(2009)1,686 cited
- → Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase(2018)365 cited
- → The Lymph Node Ratio is the Strongest Prognostic Factor after Resection of Pancreatic Cancer(2009)347 cited
- → ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)(2016)344 cited
- → ZEB 1‐associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat(2015)229 cited
- → Nonoperative Treatment of 15 Benign Esophageal Perforations With Self-Expandable Covered Metal Stents(2006)201 cited